Stem and progenitor cell-mediated tumor selective gene therapy.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
Works matching IS 09697128 AND DT 2008 AND VI 15 AND IP 14
Results: 8
1
2
Targeting gene expression to cones with human cone opsin promoters in recombinant AAV.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
3
Heat shock protein inhibitors increase the efficacy of measles virotherapy.
- Published in:
- Gene Therapy, 2008, v. 15, n. 14, p. 1024, doi. 10.1038/gt.2008.30
- By:
- Publication type:
- Article
4
Progress and prospects: gene therapy for mitochondrial DNA disease.
- Published in:
- Gene Therapy, 2008, v. 15, n. 14, p. 1017, doi. 10.1038/gt.2008.91
- By:
- Publication type:
- Article
5
Targeting gene expression to cones with human cone opsin promoters in recombinant AAV.
- Published in:
- Gene Therapy, 2008, v. 15, n. 14, p. 1049, doi. 10.1038/gt.2008.32
- By:
- Publication type:
- Article
6
Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells.
- Published in:
- Gene Therapy, 2008, v. 15, n. 14, p. 1035, doi. 10.1038/gt.2008.31
- By:
- Publication type:
- Article
7
Absence of retroviral vector-mediated transformation of gene-modified T cells after long-term engraftment in mice.
- Published in:
- Gene Therapy, 2008, v. 15, n. 14, p. 1056, doi. 10.1038/gt.2008.47
- By:
- Publication type:
- Article
8
Potential genotoxicity from integration sites in CLAD dogs treated successfully with gammaretroviral vector-mediated gene therapy.
- Published in:
- Gene Therapy, 2008, v. 15, n. 14, p. 1067, doi. 10.1038/gt.2008.52
- By:
- Publication type:
- Article